BCDA
BCDA
NASDAQ · Biotechnology

Biocardia Inc

$1.11
+0.02 (+1.83%)
As of May 16, 2:29 AM ET ·
Financial Highlights (FY 2026)
Revenue
227.0K
Net Income
-31,155,262
Gross Margin
100.0%
Profit Margin
-13,700.0%
Rev Growth
-61.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 100.0% 100.0% 36.4% 36.4%
Operating Margin -13,794.8% -12,415.4% 21.2% 22.9%
Profit Margin -13,700.0% -13,015.0% 23.4% 20.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 227.0K 590.4K 1.55M 1.32M
Gross Profit 227.0K 590.4K 562.2K 481.4K
Operating Income -31,313,436 -73,295,428 327.7K 302.8K
Net Income -31,155,262 -72,925,190 361.3K 275.7K
Gross Margin 100.0% 100.0% 36.4% 36.4%
Operating Margin -13,794.8% -12,415.4% 21.2% 22.9%
Profit Margin -13,700.0% -13,015.0% 23.4% 20.8%
Rev Growth -61.6% -61.6% +15.5% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 5.65M 6.40M
Total Equity 4.65M 5.00M
D/E Ratio 1.22 1.28
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -30,891,690 -76,325,371 534.5K 383.7K
Free Cash Flow 193.8K 220.9K